Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-025974
Filing Date
2024-11-04
Accepted
2024-11-04 16:29:58
Documents
1
Period of Report
2024-10-28

Document Format Files

Seq Description Document Type Size
1 form3-11042024_091155.html 3  
1 form3-11042024_091155.xml 3 1708
  Complete submission text file 0001415889-24-025974.txt   3398
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 15660 CHERRY BLOSSOM RD FRISCO TX 75033
Business Address
Sayad Pierre Sargis (Reporting) CIK: 0002043395 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 241424035